Oorsprong van het eerstegraads netwerk van Clas Malmeström
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
19
| Public Company | Pharmaceuticals: Major | 19 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Clas Malmeström via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal | |
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| Hunterhex AB | Director/Board Member Director/Board Member | ||
| University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Founder General Counsel | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| TOLERANZIA AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Rosland Nordic AB | Chairman | ||
The Delta Projects AB
 The Delta Projects AB Advertising/Marketing ServicesCommercial Services Part of Principion Holding BV, The Delta Projects AB is a company that provides advertising services. The company is based in Stockholm, Sweden. The Delta Projects was acquired by Principion Holding BV on July 01, 2021. The CEO of the Swedish company is John Marcus Boson Lilja. | Advertising/Marketing Services | Director/Board Member | |
Selego AB
 Selego AB Household/Personal CareConsumer Non-Durables Selego AB manufactures skin care products. The company was founded by Lars Fredriksson in 2013 and is headquartered in Stockholm, Sweden. | Household/Personal Care | Director/Board Member | |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Biotechnology | Director/Board Member | |
| Black T Quant AB | Chairman | ||
| Evolutience Pharmaceutical AB | Director/Board Member | ||
| PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
| MENDUS AB | Biotechnology | General Counsel | |
| Methra Uppsala AB | Chief Executive Officer | ||
| TERRANET AB | Information Technology Services | Director/Board Member | |
| Skatteverket | Comptroller/Controller/Auditor | ||
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Corporate Officer/Principal | |
| Challengehop, Inc. | Director/Board Member | ||
| Hunterhex International Ltd. | Director/Board Member | ||
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member | |
| Wonderboo AB | Director/Board Member | ||
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Investment Managers | Chief Executive Officer | |
| Läkemedelsindustriföreningens Service AB | Director/Board Member | ||
| Norpharma A/S | Chief Executive Officer | ||
| Mundipharma AS | Chief Executive Officer | ||
| Mundipharma Oy | Chief Executive Officer | ||
| University of Linnaeus | College/University | Undergraduate Degree | |
| Stockholm Business School | College/University | Masters Business Admin | |
| DANCANN PHARMA A/S | Pharmaceuticals: Other | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| A-Transport Jorvid AB | Corporate Officer/Principal | ||
The Organisation for Professionals in Regulatory Affairs Ltd
 The Organisation for Professionals in Regulatory Affairs Ltd Miscellaneous Commercial ServicesCommercial Services The Organisation for Professionals in Regulatory Affairs Ltd is a professional membership organization that provides training courses, conferences, and networking opportunities for individuals engaged in regulatory affairs for human and veterinary medicines and medical devices worldwide. The non-profit company is based in London, UK. The organization offers resources for improving professional competence and industry standing, including newsletters, medical device resources, and a glossary of regulatory affairs terms. | Miscellaneous Commercial Services | President | |
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SANDOZ GROUP AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tetra Pharm Technologies ApS
 Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Copenhagen Business School | College/University | Masters Business Admin | |
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
SOLVE Research & Consultancy AB
 SOLVE Research & Consultancy AB Miscellaneous Commercial ServicesCommercial Services SOLVE Research & Consultancy AB operates a contract analytical lab. The private company is based in Lund, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Financial Conglomerates | Corporate Officer/Principal | |
| Swipp AB | Chief Operating Officer | ||
| TYTO Competitive Intelligence Solutions AB | Director/Board Member |
Statistieken
Internationaal
| Zweden | 38 |
| Denemarken | 6 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Noorwegen | 2 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 59 |
| Corporate Officer/Principal | 34 |
| Chairman | 21 |
| Chief Executive Officer | 17 |
| Independent Dir/Board Member | 16 |
Sterkste connecties
| Insiders | |
|---|---|
| Karl Blom | 22 |
| Anders Waas | 21 |
| Lena Birgitta Degling Wikingsson | 16 |
| Per-Göran Gillberg | 11 |
| Julian Aleksov | 10 |
| Jan Holmgren | 10 |
| Per Wester | 10 |
| Margareth Jorvid | 9 |
| Pernilla Sandwall | 8 |
| Sebastian Hansson | 7 |
| Kirsten Harting | 7 |
| Anders Bylock | 6 |
| Carol Routledge | 6 |
| Kristina Torfgård | 5 |
| Anders Sandberg | 3 |
- Beurs
- Insiders
- Clas Malmeström
- Bedrijfsconnecties
